Factors that predict the response to interferon in patients with chronic hepatitis C: clinical management of individual patients
Lo Iacono, O.
Revista Espanola de Enfermedades Digestivas Organo Oficial de la Sociedad Espanola de Patologia Digestiva 92(8): 485-494
2000
ISSN/ISBN: 1130-0108 PMID: 11084816 Document Number: 515384
Document emailed within 1 workday
Related Documents
Ali, S.; Nazir, G.; Khan, S.A.; Iram, S.; Fatima, F. 2010: Comparative therapeutic response to pegylated interferon plus ribavirin versus interferon alpha-2b in chronic hepatitis C patients Journal of Ayub Medical College Abbottabad: Jamc 22(4): 127-130Derbala, M.F.; Amer, A.M.; El Defrawi, I.E. 2006: Anti-HCV IgM as predictor of response to interferon therapy in schistosomal patients with chronic hepatitis C Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 25(1): 44
Xu, H-tao.; Xing, T-jing.; Li, H.; Ye, J. 2012: Association of T regulatory cells with natural course and response to treatment with interferon-α in patients with chronic hepatitis B infection Chinese Medical Journal 125(8): 1465-1468
López Alonso, G. 1994: Chronic hepatitis C. Predictive factors of response to treatment with interferon Anales de Medicina Interna 11(12): 573-574
Kokoreva, L.N.; Zmyzgova, A.V.; Shalygina, N.B. 1996: The interferon therapy of patients with chronic viral hepatitis: the factors affecting the treatment results Terapevticheskii Arkhiv 68(2): 10-14
Cervantes, F.; Hernández-Boluda, J-Carlos.; Steegmann, J-Luis.; Conde, E.; Alvarez-Larrán, A.; López-Jiménez, J.; Osorio, S.; Villalón, Lía.; Camós, M.; García-Conde, J.; Odriozola, Jús. 2003: Imatinib mesylate therapy of chronic phase chronic myeloid leukemia resistant or intolerant to interferon: results and prognostic factors for response and progression-free survival in 150 patients Haematologica 88(10): 1117-1122
Hamidah, A.; Yong, J.F.; Zulkifli, H.I.; Jamal, R. 2002: Treatment of chronic hepatitis C virus infection with interferon alfa and ribavirin: sustained response in two patients with transfusion dependent thalassaemia Medical Journal of Malaysia 57(3): 353-356
Rao, H-ying.; Wei, L.; Li, J.; Zhang, L-fang.; Chen, H-yong.; Zhu, L-min.; Liu, F.; Sun, Y.; Wang, H. 2009: Liver fibrosis and hepatic stellate cells improvement of chronic hepatitis C patients by interferon-beta-1a with or without sustained viral response Hepato-Gastroenterology 56(90): 328-334
Actis, G.C.; Maran, E.; Bonino, F.; Saracco, G.; Rosina, F.; Brunetto, M.R.; Baldi, M.; Rizzetto, M.; Verme, G.; Rocca, B. 1987: Patterns of natural killer cell function activation in response to interferon in chronic HBsAG positive hepatitis: relationship with the state of viral infection and with the early clinical response Journal of Biological Regulators and Homeostatic Agents 1(1): 45-50
Srivastava, S.; Bertagnolli, M.; Lewis, J.H. 2005: Sustained virological response rate to pegylated interferon plus ribavirin for chronic hepatitis C in African Americans: results in treatment-naïve patients in a university liver clinic Journal of the National Medical Association 97(12): 1703-1707
Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908
Bizid, S.; Ben Abdallah, H.; Kilani, I.; Mohamed, G.; Bouali, R.; Abdelli, N. 2013: Predictive factors of response to peginterferon and ribavirin in Tunisians patients with chronic hepatitis C: report of 141 cases La Tunisie Medicale 91(5): 327-331
Mels, G.C.; Roffi, L.; Antonelli, G.; Bellati, G.; Pacchetti, S.; Di Nolfo, M.A.; Panizzuti, F.; Moretti, G.; Piperno, A.; Pozzi, M. 1993: Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy Progress in Clinical and Biological Research 382: 359-364
Bernardinello, E.; Cavalletto, L.; Chemello, L.; Mezzocolli, I.; Donada, C.; Benvegnú, L.; Merkel, C.; Gatta, A.; Alberti, A. 1999: Long-term clinical outcome after beta-interferon therapy in cirrhotic patients with chronic hepatitis C. TVVH Study Group Hepato-Gastroenterology 46(30): 3216-3222
Hinoue, Y.; Unoura, M.; Kato, Y.; Kobayashi, K.; Hattori, N. 1984: Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(2): 205-211
Baba, T.; Makino, R.; Shibata, M.; Harada, E.; Mitamura, K. 1997: Interferon treatment for hepatitis G virus infection in patients with chronic hepatitis C Nihon Rinsho. Japanese Journal of Clinical Medicine 55(3): 625-630
Tseng, T-Chung.; Liu, C-Jen.; Wang, C-Chi.; Chen, P-Jer.; Lai, M-Yang.; Chen, D-Shinn.; Kao, J-Horng. 2009: Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels Antiviral Therapy 14(2): 203-210
Kakumu, S.; Ishikawa, T.; Wakita, T.; Yoshioka, K.; Takayanagi, M.; Tahara, H.; Kusakabe, A. 1994: Interferon-gamma production specific for hepatitis B virus antigen by intrahepatic T lymphocytes in patients with acute and chronic hepatitis B American Journal of Gastroenterology 89(1): 92-96
Zuberi, S.J.; Alam, S.E.; Raza, S. 1994: Interferon alpha 2a in patients of chronic hepatitis C Jpma. Journal of the Pakistan Medical Association 44(7): 171-172
Rabinovitz, M.; Block, G.; Finkelstein, S.D. 1996: Alpha-Interferon retreatment of patients with chronic hepatitis C American Journal of Gastroenterology 91(8): 1523-1526